If needed and tolerated, the dose may increase in 2.5 mg steps, typically after at least 4 weeks at each dose
Novo acquired exclusive rights to develop, manufacture, and commercialize UBT-251 outside of mainland China, Hong Kong, Macau, and Taiwan
Modest heart rate increases are generally well-tolerated, but contact your doctor if you experience symptomatic tachycardia, persistent palpitations, or resting heart rate consistently exceeding 100 beats per minute
If you have a glucose meter, increase the frequency of testing during the first 2-4 weeks after stopping Trulicity
Chang, Yun-Hsuan, et al
Discover what sets us apart: Medical Mastery: Our board-certified doctors and nurse practitioners have the expertise to guide your weight loss journey safely and effectively